Unecritinib

Generic Name: Unecritinib

Brand Names: -

Drug Type: -

Chemical Formula: C_₂₃H_₂₄Cl_₂FN_₅O_₂

CAS Number: -

Unique Ingredient Identifier: -

Indication: 用于ROS1阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的治疗。

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

Phase 1

Completed

Conditions: Pharmacokinetic Study

Interventions: Drug: TQ-B3101

First Posted Date: 2021-03-18

Last Posted Date: 2022-01-21

Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Target Recruit Count: 16

Registration Number: NCT04804904

Locations: 🇨🇳
Zhongshan Hospital of Fudan University, Shanghai, Shanghai, China

A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

Phase 2

Conditions: Advanced Malignant Tumor

Interventions: Drug: TQ-B3101

First Posted Date: 2020-06-02

Last Posted Date: 2020-08-18

Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Target Recruit Count: 200

Registration Number: NCT04412564

Locations: 🇨🇳
Shanghai Jiaotong University Affiliated Chest Hospital, Shanghai, Shanghai, China
🇨🇳
Anhui Chest Hospital, Hefei, Anhui, China
🇨🇳
The Second Hospital of Anhui medical University, Hefei, Anhui, China

and more 33 locations

Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Conditions: ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Interventions: Drug: TQ-B3101

First Posted Date: 2019-06-03

Last Posted Date: 2019-08-15

Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Target Recruit Count: 111

Registration Number: NCT03972189

Locations: 🇨🇳
Tumor hospital, Chinese academy of medical sciences, Beijing, Beijing, China
🇨🇳
Henan Tumor Hospital, Zhengzhou, Henan, China
🇨🇳
Affiliated tumor hospital of sun yat-sen university, Guangzhou, Guangdong, China

and more 19 locations

A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics

Phase 1

Conditions: Advanced Cancer

Interventions: Drug: TQ-B3101

First Posted Date: 2017-01-12

Last Posted Date: 2017-09-18

Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Target Recruit Count: 20

Registration Number: NCT03019276

Locations: 🇨🇳
Sir Run Run Shaw Hospital,School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy